Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
about
Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityGenetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasetsPharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose.Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral NeuropathyGenomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.Natural variation in a single amino acid substitution underlies physiological responses to topoisomerase II poisons.Evaluating the role of admixture in cancer therapy via in vitro drug response and multivariate genome-wide associations.Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer.Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.Natural diversity facilitates the discovery of conserved chemotherapeutic response mechanisms.Genetic background influences susceptibility to chemotherapy-induced hematotoxicity.Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.
P2860
Q28083100-27721195-0C4D-4917-877A-C6F556E8F7F1Q28392307-C39536C8-F5E7-43B3-BD29-ED5A28A6FC1BQ35674153-AE33D9BE-8A18-4058-AC03-E13830D6A722Q36117686-7F208862-501D-4210-8917-CCC57C861951Q37323259-80CD095A-D790-4E6C-90C1-D338ED39FB57Q38513661-7DF8E879-522D-4D4E-86CC-9D0DEF00BC07Q38682376-74B92A08-3ACF-4BEF-983D-ACD4B149A5E4Q38840322-4392C6CD-AFE6-4E53-8A10-71F095F75C47Q38922471-413AD649-2E51-4C75-8EB4-04DE21E70E80Q39262358-F3738695-4EC9-43E3-9F35-CC086855C871Q39701080-9B14D387-7C7D-4152-B249-FFB4318BE02DQ42585707-77484236-B7DF-44CD-93D7-65107BCC350DQ46308923-0CE5EA12-1310-4AE4-A0B1-1729BF1B4F86Q47094464-FB646B38-B60B-40EB-B295-4EF56786C028Q47425743-2D295302-5A56-450E-B76E-6333757CDF8E
P2860
Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genome-wide association study ...... for patients in Biobank Japan.
@ast
Genome-wide association study ...... for patients in Biobank Japan.
@en
Genome-wide association study ...... for patients in Biobank Japan.
@nl
type
label
Genome-wide association study ...... for patients in Biobank Japan.
@ast
Genome-wide association study ...... for patients in Biobank Japan.
@en
Genome-wide association study ...... for patients in Biobank Japan.
@nl
prefLabel
Genome-wide association study ...... for patients in Biobank Japan.
@ast
Genome-wide association study ...... for patients in Biobank Japan.
@en
Genome-wide association study ...... for patients in Biobank Japan.
@nl
P2093
P2860
P921
P356
P1433
P1476
Genome-wide association study ...... for patients in Biobank Japan
@en
P2093
Atsushi Takahashi
Hitoshi Zembutsu
Michiaki Kubo
Suyoun Chung
Taisei Mushiroda
Yusuke Nakamura
P2860
P304
P356
10.1111/CAS.12186
P50
P577
2013-06-10T00:00:00Z